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ABSTRACT
Background: Reversed Robin Hood syndrome (RRHS) has recently been identified as one of the
mechanisms of early neurologic deterioration in acute ischemic stroke (AIS) patients related to
arterial blood flow steal from ischemic to nonaffected brain. We sought to investigate the associ-
ation of RRHS with risk of stroke recurrence in a single-center cohort study.
Methods: Consecutive patients with AIS or TIA affecting the anterior circulation were prospec-
tively evaluatedwith serial NIH Stroke Scale assessments and bilateral transcranial Doppler mon-
itoring with breath-holding test. RRHS was defined according to previously validated criteria.
Results: A total of 360 patients (51% women, mean age 62  15 years) had an ischemic stroke
(81%) or TIA (19%) in the anterior circulation, and 30 (8%) of them had RRHS. During a mean
follow-up period of 6 months (range 1–24), a total of 16 (4%) recurrent strokes (15 ischemic and
1 hemorrhagic) were documented. The cumulative recurrence rate was higher in patients with
RRHS (19%; 95% confidence interval [CI] 1–37) compared to the rest (15%; 95% CI 0–30; p 
0.022 by log-rank test). All recurrent strokes in patients with RRHS were cerebral infarcts that
occurred in the ipsilateral to the index event anterior circulation vascular territory. After adjusting
for demographic characteristics, vascular risk factors, and secondary prevention therapies,
RRHSwas independently associatedwith a higher stroke recurrence risk (hazard ratio 7.31; 95%
CI 2.12–25.22; p 0.002).
Conclusions: Patients with AIS and RRHS appear to have a higher risk of recurrent strokes that
are of ischemic origin and occur in the same arterial territory distribution to the index event.
Further independent validation of this association is required in a multicenter setting. Neurology®
2010;75:2003–2008
GLOSSARY
AIS  acute ischemic stroke; BHI  breath-holding index; BP  blood pressure; CE  cardioembolic stroke; CI  confidence
interval; HR  hazard ratio; ICH  intracerebral hemorrhage; IS  ischemic stroke; IUC  infarct of undetermined cause;
LAA  large artery atherosclerotic stroke; LAC  lacunar stroke; MFV  mean flow velocity; MRA  magnetic resonance
angiography; mRS  modified Rankin Scale; NIHSS  NIH Stroke Scale; RVT  registered vascular technologists; RRHS 
reversed Robin Hood syndrome; SM  steal magnitude; TCD  transcranial Doppler; TOAST  Trial of Org 10172 in Acute
Stroke Treatment.
The underlying causes of neurologic deterioration in acute ischemic stroke (AIS) patients
comprise several different mechanisms including arterial reocclusion, cardiovascular instability,
edema progression, and hemorrhagic transformation.1-5 Real-time monitoring with transcra-
nial Doppler (TCD) may assist in identifying hemodynamic causes of early deterioration.5-9
One of the mechanisms related to infarct expansion, leading to neurologic deterioration in the
setting of acute cerebral ischemia, is an intracranial arterial blood flow steal phenomenon in
patients with proximal arterial occlusions.8,9 More specifically, with hypercapnia, flow veloci-
ties paradoxically decrease in the vessels supplying ischemic tissues at the time of velocity
increase in the normal arteries, which are able to respond to the carbon dioxide stimulus with a
more effective vasodilation. The intracranial steal phenomenon can be quantified by TCD as
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mean flow velocity reduction during volun-
tary breath-holding.8 If this steal phenome-
non leads to neurologic deterioration, the
reversed Robin Hood syndrome (RRHS) is
diagnosed.8,9
The prevalence of intracranial steal phe-
nomenon and RRHS in consecutive patients
with acute cerebral ischemia was 14% and
7%.9 Patients with proximal arterial occlu-
sions and excessive daytime sleepiness ap-
peared particularly vulnerable to the steal that
was documented exclusively in the anterior
circulation.9 Furthermore, patients with
RRHS tended to have less neurologic im-
provement at hospital discharge.9 We hypoth-
esized that this acute and symptomatic
hemodynamic compromise could also predis-
pose the patient to a new stroke occurrence.
We attempted to evaluate the potential associ-
ation of RRHS with the risk of stroke recur-
rence in consecutive patients with acute
cerebral ischemia.
METHODS Study design. Consecutive patients with symp-
toms of acute anterior cerebral ischemia, admitted within 48
hours from symptoms onset to our tertiary hospital stroke service
from November 2007 through December 2009, were prospec-
tively evaluated. Adults with an anterior circulation ischemic
stroke (with neuroimaging evidence of acute cerebral infarction
in the distribution of anterior circulation) or a TIA, at least 19
years old, with temporal windows for TCD examination, who
consented to participate in the study were included. According
to the Trial of Org 10172 in Acute Stroke Treatment (TOAST)
criteria, ischemic strokes were classified based on etiopathoge-
netic mechanisms into the following groups: large artery athero-
sclerotic stroke (LAA), cardioembolic stroke (CE), small artery
occlusion or lacunar stroke (LAC), and infarct of undetermined
cause (IUC).10 Consecutive TCD evaluations were performed on
a daily basis during hospitalization to document the presence of
reocclusion as a cause of deterioration.
Neurologic deficits were measured by serial NIH Stroke
Scale (NIHSS) scores obtained by certified stroke team mem-
bers. Neurologic deficits were assessed using NIHSS evaluations
on a daily basis during hospitalization. Demographics and com-
mon risk factors were documented from routine stroke workup
as previously described.8,9
TCD evaluation. Standard diagnostic TCD and bilateral
TCD monitoring with voluntary breath-holding8,9,11 or during
spontaneous apneas8,9 were performed by registered vascular
technologists (RVT), or RVT-eligible sonographers within 24
hours from hospitalization. TCD monitoring of the symptom-
atic and asymptomatic sides was performed simultaneously
(Spencer’s ST3 TCD, Seattle, WA). As an indirect measure of the
effectiveness of breath-holding in producing hypercapnia, we
used the increase in mean flow velocity (MFV) in the asymptom-
atic side which was quantified as a breath-holding index (BHI)
of 0.69 at the end of breath-holding.12 If the BHI in the non-
affected vessel was 0.69, the breath-holding procedure was re-
peated. No case was excluded from the present study on the basis
of ineffective breath-holding or absence of spontaneous apneas.
We measured the MFV changes during 15–30 seconds of
breath-holding.8 A proximal arterial obstruction was diagnosed
when an occlusion or 70% stenosis of the extracranial ICA,
intracranial ICA, or M1 MCA was detected from CT or mag-
netic resonance angiography (MRA) as previously described.13-15
The time elapsed between baseline TCD assessment and CTA or
MRA was less than 48 hours in all cases. Collaterals on TCD
were identified using previously validated criteria.13-15
The hemodynamic steal was defined as MFV decrease in the
affected vessel at the time of hypercapnia-induced velocity in-
crease in the normal MCA. The vascular steal phenomenon had
to occur in the vascular territory considered responsible for the
ischemic stroke or TIA for the patient to be classified as having
RRHS.8,9 The steal magnitude (SM, %) was quantified as the
maximum negative percent velocity reduction during breath-
holding as previously described: SM  [(MFVm  MFVb)/
MFVb]  100, where m  minimum and b  baseline
MFVs.8,9 Steal was considered present when SM was negative,
i.e., SM 0 in the affected vessel. After the steal was docu-
mented on TCD, RRHS was suspected if new or recurrent neu-
rologic worsening by 2 NIHSS points was observed without
concurrent changes in blood pressure (BP) or arterial patency.8,9
Follow-up evaluation. Functional independence at hospital
discharge and after a recurrent stroke was evaluated using the
modified Rankin Scale (mRS). Patients with mRS score of 0–2
were considered as functionally independent.16 The secondary
prevention therapies were selected by the treating physicians ac-
cording to the current American Heart Association recommen-
dations and were documented in all cases.17
All surviving patients were followed up prospectively at reg-
ular intervals after the index event by a study investigator and a
trained nurse during the follow-up period. The outcome events
of interest were recurrent strokes and deaths. To determine re-
current ischemic stroke (IS) or intracerebral hemorrhage (ICH),
we evaluated all the available information obtained from death
certificates, hospital records, physicians’ notes in private practice,
necropsy findings, and the patients’ clinical presentation at the
regular follow-up assessments. Recurrent stroke was defined as a
sudden onset of neurologic deficit that persisted more than 24
hours and clearly resulted in a new neurologic deficit or an in-
crease in an existing deficit.18 Brain imaging demonstrating a
new lesion, involving a different anatomic site or vascular terri-
tory from the index event, was mandatory to support the diagno-
sis of recurrent stroke during the first 3 weeks after stroke onset.
The location of cerebral infarctions (anterior vs posterior circula-
tion, ipsilateral vs contralateral to the index ischemic event) was
documented in all recurrent ischemic strokes.
Standard protocol approvals, registrations, and patient
consents. Our Institutional Review Board approved the
present study. We received written informed consent from all
patients participating in the study or their guardians.
Statistical analyses. Statistical analyses were performed with
the SPSS 15.0 software (SPSS Inc.). The 2-tailed Fisher exact
test or Pearson 2 test for categorical variables and Student t test
or Mann-Whitney U test for continuous variables were used to
assess intergroup differences. Data are presented as mean (SD) or
as percentages. The Kaplan-Meier product-limit method was
used to estimate the cumulative probability of survival and recur-
rence during the follow-up period from the index event. Kaplan-
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Meier curves of groups with and without RRHS are presented
and survival free of stroke recurrence is compared between the 2
groups using the log-rank method. To evaluate which factors
contribute to long-term recurrence, we performed Cox propor-
tional hazards analyses. Those factors that contributed to the
outcome in the initial univariate analyses at p  0.2 (because of
the risk of type II error due to low statistical power in such an
analysis) were included in the multivariate model as candidate
variables. The final variables that were independently associated
in the multivariate analyses with stroke recurrence were selected
by forward stepwise selection procedure using a p value 0.05.
To confirm the robustness of multivariate models, we also per-
formed all multivariate analyses using a backward-selection pro-
cedure. Associations are presented as hazard ratios (HR) with
corresponding 95% confidence intervals (95% CI).
RESULTS A total of 360 of the 581 patients admit-
ted to our stroke service during the study period
(51% women, mean age 62  15 years; 81% AIS,
19% TIA) fulfilled our inclusion criteria. Twelve pa-
tients were unable to perform voluntary breath-
holding and the presence of intracranial steal
phenomenon was identified during spontaneous
apneas. RRHS was identified in 30 cases (8%, 29
during voluntary breath-holding and 1 during spon-
taneous apneas). Demographic characteristics, vascu-
lar risk factors, and secondary prevention therapies of
the study population are shown in table 1. Male gen-
der was more common in RRHS patients (77% vs
47%; p  0.002). RRHS was more prevalent in
white subjects (11%) compared with African Ameri-
can subjects (4%; p 0.031). The underlying stroke
pathogenic mechanism was LAA in 67% of patients
with RRHS and in 28% of those without RRHS
(p  0.0001). In addition, patients with RRHS had
a higher prevalence of proximal arterial obstruction
(93% vs 26%, p  0.0001). Patients with RRHS
tended to have lower functional independence rates
at hospital discharge (43% vs 58%; p  0.124).
During a mean follow-up period of 6 months
(range 1–24), a total of 16 (4%) recurrent strokes (15
ischemic and 1 hemorrhagic) were documented. The
duration of follow-up period was similar between pa-
tients with RRHS (6.6  8.2 months) and patients
without TCD evidence of intracranial steal phenom-
enon (6.0 7.2 months; p 0.653). Four out of the
16 (25%) recurrent strokes were fatal. The cumula-
tive recurrence rate was higher in patients with
RRHS (19%; 95% CI 1–37) compared to the rest
(15%; 95% CI 0–30; p  0.022 by log-rank test;
figure). All recurrent strokes in patients with RRHS
were cerebral infarcts in the anterior circulation vas-
cular territory ipsilateral to the index event. The
mean elapsed time between the index and the recur-
rent stroke tended to be shorter in patients with
RRHS (1.2  1.8 months) compared to the rest
(4.7 6.4 months; p 0.110). The 1-month stroke
recurrence rate was 4-fold higher in RRHS (12%;
95% CI 0–25) compared to the rest (3%; 95% CI
1–5; p  0.015 by log-rank test). Factors associated
with a higher risk of stroke recurrence in the univari-
ate and multivariate Cox regression models are
shown in table 2. In the initial univariate analyses,
the following factors were selected for inclusion in
the multivariate model: RRHS, age, coronary artery
disease, and AIS (vs TIA). In the final multivariate
analyses (performed by forward selection procedure),
RRHS, age, and coronary artery disease were inde-
pendently related to the risk of stroke recurrence.
The presence of RRHS was independently associated
with a higher risk of stroke recurrence (HR 7.31;
95% CI 2.12–25.22; p  0.002). After performing
the multivariate analyses using a backward selection
procedure, we obtained practically identical results
regarding the relationship of RRHS with risk of
stroke recurrence (HR 5.90; 95% CI 1.70–20.22;
p  0.005).
We also excluded patients who were unable to
perform voluntary breath-holding (n  12) and re-
peated our analyses. RRHS was independently asso-
ciated with a higher risk of stroke recurrence (HR
12.45; 95% CI 2.78–55.68; p  0.001). Since the
number of outcome events was low (n  16), the
maximum number of predictor variables that should
Table 1 Baseline characteristics of the study
population (n 360)a
Variable Value
Age, y, mean (SD) 62 (15)
Male gender 178 (49)
African American ethnicity 138 (38)
Acute ischemic stroke 290 (81)
Transient ischemic attack 70 (19)
Stroke severity on admission: NIH Stroke
Scale score, median (interquartile range)
4 (9)
Large-artery atherosclerotic stroke 111 (31)
Proximal arterial obstruction 115 (32)
Hypertension 316 (88)
Diabetes mellitus 142 (39)
Coronary artery disease 118 (33)
Atrial fibrillation 68 (19)
Smoking 163 (65)
Hypercholesterolemia 283 (79)
Aspirin at hospital discharge 172 (48)
Other antiplatelet at hospital discharge 145 (40)
Oral anticoagulants at hospital discharge 43 (12)
Lipid-loweringmedication at hospital
discharge
318 (88)
Blood-pressure loweringmedication at
hospital discharge
316 (88)
a Values are n (%) unless otherwise indicated.
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be included in the multivariate model would be 2. If
a more stringent cutoff was used in the univariate
analyses ( p  0.150), then only RRHS ( p 
0.032) and coronary artery disease (p  0.116)
would be eligible for inclusion in the multivariate
model [age (p  0.165) and AIS (p  0.198)
would be excluded from the final model]. In this
case, the association between RRHS and risk of
stroke recurrence would be attenuated (HR 4.54;
95% CI 1.43–14.39; p  0.010).
During the follow-up period, 33 patients died
(9%). The cumulative survival rate was similar in pa-
tients with RRHS (84%; 95% CI 66–100) com-
pared to the rest (85%; 95% CI 78–82; p  0.947
by log-rank test). On univariate Cox regression mod-
els, RRHS was not associated with a higher risk of
death (HR 1.04; 95% CI 0.32–3.41; p  0.947).
DISCUSSION Our study showed that patients with
acute anterior circulation ischemic events and RRHS
have a significantly higher risk of new ischemic
stroke occurrence during follow-up than acute stroke
patients without this condition. This longitudinal as-
sociation persisted even after adjustment for demo-
graphic characteristics, vascular risk factors, and
secondary prevention therapies. We also observed
that all recurrent strokes in the RRHS subgroup oc-
curred in the anterior circulation vascular territory
ipsilateral to the index event. A trend for earlier re-
current strokes was also noted in the RRHS group
(75% of recurrent strokes occurred during the first
month).
Our study confirmed the previously reported
prevalence of RRHS among patients with AIS or
TIA and their demographic characteristics (white
men were predominant in this specific population).9
We also corroborated the previously observed signif-
icant association between RRHS and proximal arte-
rial obstruction,8,9 as well as the higher prevalence of
large vessels disease as underlying pathogenetic
mechanism in patients with RRHS, although it
should be noted that 11 out of the 30 patients with
RRHS were included in the previous publication
from our group.9 Patients with LAA stroke have a
higher risk of recurrent stroke compared to other AIS
subtypes,19 while intracranial arterial occlusions or
hemodynamically significant stenoses (70%) also
carried a substantial risk of stroke recurrence.20 Inter-
estingly, in our series the relationship of RRHS with
higher incidence of stroke recurrence persisted even
after adjustment for TOAST subtype and the pres-
ence of proximal arterial obstruction. This finding
indicates that the hemodynamic compromise caused
by the vascular steal phenomenon may be an under-
lying mechanism linking large vessel atherosclerosis
both with neurologic deterioration in the acute
stroke setting as well as with recurrent cerebral isch-
emia during the first months after the index. The fact
that all recurrent strokes in RRHS subgroup oc-
curred in the same anterior circulation vascular terri-
tory, with the majority taking place during the first
month of ictus, is consistent with the former hypoth-
esis. However, it should be noted that given the rela-
tively small sample size of outcome events (n  16),
the present observation might only be valid for hy-
pothesis generation and require independent valida-
tion from other groups.
To our knowledge, the potential association be-
tween RRHS and recurrent stroke had not been pre-
viously evaluated either in a cross-sectional or in a
longitudinal fashion. The high cumulative stroke re-
currence, both during the first month (12%) and
during a mean follow-up period of 6 months (19%),
may raise certain potential clinical implications.
Given the noninvasive nature of TCD, the short
time required to document this vascular steal phe-
nomenon during voluntary breath-holding, and the
satisfactory interobserver agreement for TCD diag-
nosis of RRHS among experienced sonographers
(Cohen   0.89),9 RRHS may constitute an easily
identifiable cause of neurologic deterioration and early
stroke recurrence among patients with acute cerebral
ischemia. Furthermore, in our previous studies we ob-
served an association between RRHS and the likelihood
Figure Kaplan-Meier curves of patients with and without reversed Robin
Hood syndrome (RRHS) surviving free from recurrent stroke from
time of index event
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of obstructive sleep apnea and we noted neurologic im-
provement when patients with obstructive sleep apnea
syndrome and RRHS were placed on biphasic positive
airway pressure treatment.8,9 We hypothesized that
changes in blood carbon dioxide concentration in AIS
with hemodynamic impairment may represent the
missing link between stroke recurrence and obstructive
sleep apnea.8,9 The present study findings in combina-
tion with our former observations motivate us to for-
mally investigate this intriguing hypothesis in a future
study using early hemodynamic assessment of collateral
flow, monitoring of respiratory function, and formal
sleep study in AIS patients. If we provide additional
evidence confirming that hypercapnia is indeed induc-
ing the steal phenomenon in AIS with obstructive sleep
apnea, which in turn causes neurologic deterioration
and early stroke recurrence, this may open a novel
promising technological venue to further explore non-
invasive ventilatory correction in this specific stroke
subgroup in terms of reduction of recurrent stroke.21,22
Our study has certain limitations that need to be
acknowledged. First and most important, both the
duration of the follow-up period and the number of
outcome events were limited. Because this was a
single-center study, a type II error may not be ex-
cluded. This is the reason we chose to select a univar-
iate p value of 0.2 as a cutoff for inclusion of
predictor variables in the final multivariable model.
However, it should be noted that the maximum
number of predictor variables that should be in-
cluded in the multivariate models should be 2 given
the limited number of outcome events (n 16). On
the other hand, it is worth mentioning that when we
applied a more stringent cutoff in the univariate anal-
yses (p  0.150), only 2 variables were included in
the multivariable model, while the association of
RRHS with higher risk of recurrent stroke despite
being attenuated retained its significance (p 
0.010). Second, we used a single short-duration ul-
trasound test that provides only a snapshot and does
not answer the question of what happens to the steal
over time. Moreover, a subgroup of patients (n  12)
was unable to perform voluntary breath-holding and in
these patients the presence of steal phenomenon was
documented during spontaneous apneas.8 This issue
may have biased the reported associations, although it is
noteworthy that the association between RRHS and
higher risk of stroke recurrence persisted even after ex-
clusion of noncompliant patients.
Third, TCDmay reliably detect this vascular steal
only in proximal anterior circulation vessels (contin-
uous TCD monitoring of intracranial arteries at a
steady angle of insonation can be achieved only via
the transtemporal window using a headframe),8,9
and, therefore, we may have missed the presence of
RRHS in more distal anterior circulation vessels
(e.g., M3MCA) as well as the posterior circulation.
Patient evaluation by simultaneous use of other tech-
niques able to investigate cerebral hemodynamics
distally (e.g., near infrared spectroscopy)23 may en-
able us to address this issue in the future. Fourth, we
performed no monitoring of respiratory function,
and subsequently, we are unable to evaluate a poten-
tial relationship between hypercapnia and stroke re-
currence. Fifth, our ultrasonographic criteria for
RRHS may be technically challenging for inexperi-
enced sonographers. In view of the former method-
ologic shortcomings, we consider that our findings
regarding the association of RRHS with higher risk
of recurrent stroke should be cautiously interpreted
and replicated in a larger series of patients by other
independent investigators using both ultrasound and
other neuroimaging modalities (e.g., single photon
emission computed tomography)23 for vasomotor re-
activity assessment. Sixth, in patients with persisting
arterial occlusions, the sluggish flow may impair the
washout of emboli and thus it may be postulated that
artery-to-artery embolization may also contribute to
Table 2 Univariate andmultivariate Cox proportional hazard analyses
determining the effect of different factors on recurrence
Dependent variable: baseline
characteristics
Univariate analysis Multivariate analysisa
Hazard ratio
(95%CI) p
Hazard ratio
(95%CI) p
Age (per 10-year increase) 1.27 (0.91–1.78) 0.165 1.49 (1.06–2.10) 0.021
Male gender 1.37 (0.51–3.67) 0.534
African American ethnicity 1.53 (0.58–4.08) 0.393
Hypertension 23.83 (0.02–33,051.89) 0.390
Diabetes mellitus 1.18 (0.44–3.16) 0.750
Hypercholesterolemia 0.72 (0.23–2.27) 0.576
Smoking 1.20 (0.45–3.20) 0.719
Coronary artery disease 0.30 (0.07–1.34) 0.116 0.18 (0.04–0.83) 0.028
Atrial fibrillation 1.81 (0.63–5.26) 0.273
AIS vs TIA 29.52 (0.17–5,093.12) 0.198
Admission NIHSS (per
1-point increase)
1.03 (0.96–1.10) 0.397
Large artery atherosclerotic
stroke
1.02 (0.35–2.93) 0.977
Proximal arterial obstruction 1.21 (0.44–3.32) 0.717
RRHS 3.46 (1.11–10.76) 0.032 7.31 (2.12–25.22) 0.002
Antihypertensivemedicationsb 23.83 (0.02–33,051.89) 0.390
Lipid-loweringmedicationsb 0.58 (0.22–1.54) 0.272
Aspirin (vs other antiplatelet
agent)b
0.87 (0.33–2.32) 0.783
Oral anticoagulantsb 0.48 (0.06–3.62) 0.474
Abbreviations: AIS acute ischemic stroke; CI confidence interval; NIHSS NIH Stroke
Scale score; RRHS reversed Robin Hood syndrome.
a Forward selection procedure.
b At hospital discharge.
Neurology 75 November 30, 2010 2007
the documented association between RRHS and re-
current stroke. Unfortunately, formal emboli moni-
toring (lasting at least 1 hour) was not performed in
our dataset and we plan to evaluate this timely issue
(artery-to-artery embolism in patients with proximal
arterial occlusions and RRHS) in a future study.
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